Ignite Creation Date:
2024-05-06 @ 2:37 PM
Last Modification Date:
2024-10-26 @ 1:34 PM
Study NCT ID:
NCT04379635
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-20
First Post:
2020-05-04
Brief Title:
Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer NSCLC
Sponsor:
BeiGene
Organization:
BeiGene
Organization Data
Organization:
BeiGene
Class:
INDUSTRY
Study ID:
BGB-A317-315
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BeiGene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None